1. Home
  2. ILAG vs ENVB Comparison

ILAG vs ENVB Comparison

Compare ILAG & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

HOLD

Current Price

$3.28

Market Cap

7.2M

ML Signal

HOLD

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

HOLD

Current Price

$1.35

Market Cap

8.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ILAG
ENVB
Founded
1981
1994
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
8.1M
IPO Year
2020
2000

Fundamental Metrics

Financial Performance
Metric
ILAG
ENVB
Price
$3.28
$1.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
744.0
125.0K
Earning Date
04-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,914,675.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.56
52 Week High
$7.19
$13.25

Technical Indicators

Market Signals
Indicator
ILAG
ENVB
Relative Strength Index (RSI) 47.34 43.48
Support Level $3.16 N/A
Resistance Level $3.31 $1.54
Average True Range (ATR) 0.10 0.12
MACD -0.01 -0.01
Stochastic Oscillator 60.00 44.43

Price Performance

Historical Comparison
ILAG
ENVB

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Taiwan.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: